Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
772
Total Claims
$218K
Drug Cost
70
Beneficiaries
$3,111
Cost/Patient
Risk Score Breakdown 35/100
Score components are additive. Read full methodology
Peer Comparison vs. 8,541 Hematology-Oncology providers
+765%
Opioid rate vs peers
54.3% vs 6.3% avg
-77%
Cost per patient vs peers
$3,111 vs $14K avg
+6%
Brand preference vs peers
15.4% vs 14.6% avg
⚠️ This provider has metrics more than 3 standard deviations above their specialty average in one or more categories.
🔎 Data Overview
Opioid prescribing rate is 765% above the average for Hematology-Oncology providers. While some providers legitimately treat pain-heavy populations, deviations of this magnitude are rare and warrant examination.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
54.3%
Opioid Rate
419
Opioid Claims
$58K
Opioid Cost
21.0%
Long-Acting Rate
This provider's opioid prescribing rate of 54.3% is above the 20% threshold that CMS considers elevated.
Brand vs Generic
Brand: 119 claims · $184K
Generic: 653 claims · $34K
Patient Profile
42
Avg Age
57%
Female
5.06
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About